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Drug Courts in Vermont: 
Will this approach reduce recidivism 
among heroin users? 
Vermont is often thought of as a peaceful, bucolic place, steeped in tradition and rural 
appeal. Although this picture is accurate, it fails to account for the overall changes occurring in 
Vermont. Vermont is a predominately rural state with a fairly homogenous population of I-
619,107 (U.S. Census Bureau, 2003). The state's largest community, Burlington, hosts over 
150,000 members of this population and is the only community with a metropolitan status by 
U.S. Census Bureau standards. With a density of 65 persons/square mile (U.S. Census Bureau, 
Quickfacts, 2003), Vermont is quite rural by most measures. However, even in this rural haven 
of dairy farms and activist ice cream businesses, the use and abuse of heroin is rising 
dramatically. 
As with most use of illicit substances, facts and figures on users and addicts is anecdotal 
at best and the public health community is forced to rely on statistics gathered from law 
enforcement agencies, the judiciary and treatment providers. This methodology is flawed as so 
many escape any of these modes of classification. But, as with other large sample surveys of a 
population, this evidence can be indicative of the population as a whole (L. Gordis, 2000). 
In 1997, the State of Vermont's Office of Alcohol and Drug Abuse Programs (ADAP), 
reported 113 people seeking treatment for heroin (National Drug Intelligence Center, 2003). By 
2000, this number had grown to 373, an increase of237% (National Drug Intelligence Center). 
Between 2000 and 2001, admissions had jumped to 696, an 87% increase in one year (National 
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Drug Intelligence Center). The state population had not grown more than 1.7% (U.S. Census 
Bureau) over the same period. The number of those admissions among 18-24 year olds increased 
by 464% in that same period from 22 to 124 (National Drug Intelligence Center). Deaths from 
heroin overdoses went from 4 in 1997 to 14 in 2000 (National Drug Intelligence Center). The 
numbers on heroin arrests from state and local law enforcement agencies rose from 10 in 1997 to 
86 in 2000 (National Drug Intelligence Center). 
The Vermont Center for Justice Research collects data by government mandate on crime 
in the state of Vermont. Although their statistics do not account for federal indictments, or 
D.E.A. arrests, they do capture the arrest and disposition statistics from State and Local law 
enforcement as well as the judiciary. As evident in the chart below, heroin related offenses, both 
sale and possession are increasing dramatically in Vermont. Although males and persons aged 25 
or older have predominate representation, the trend among youth, aged 18-24 and females is 
rising precipitously. 
Age and Age and 
Drug Offense 2000 2001 2002 2003 Drug Offense 2000 2001 2002 2003 
~s16-17 Ages 21-25 
Possession Possession 
Heroin 2 1 3 5 Heroin 15 26 44 38 
LSD 1 1 0 0 LSD 2 1 0 3 
Marijuana 200 234 227 179 Marijuana 349 423 465 422 
Cocaine 4 2 7 12 Cocaine 19 21 52 52 
Sale Sale 
Heroin 0 0 0 3 Heroin 9 15 18 28 
LSD 0 0 0 0 LSD 7 0 1 1 
Marijuana 2 3 6 4 Marijuana II 14 10 24 
Cocaine 0 0 3 6 Cocaine I 31 19 42 
Al!es 18-20 Al!es ~6 
Possession Possession 
Heroin 30 16 24 23 Heroin 37 66 70 76 
LSD 4 3 0 I LSD 1 0 I 0 
Marijuana 475 534 598 480 Marijuana 622 656 643 637 
Cocaine 10 21 30 30 Cocaine 64 103 107 100 
Sale Sale 
Heroin 11 7 10 16 Heroin 22 27 78 43 
LSD 0 0 0 2 LSD 0 I 0 0 
Marijuana 12 4 26 23 Marijuana 16 25 20 68 
Cocaine 3 13 13 22 Cocaine 20 33 36 78 
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I Sex Drug Offense 2000 2001 2002 2003 
Male Possession 
Heroin 52 62 98 89 
LSD 8 5 1 4 
Marijuana 1,384 1,575 1,625 1,447 
Cocaine 73 107 158 128 
Sale 
Heroin 31 40 75 67 
LSD 3 I 0 3 
Marijuana 40 34 45 87 
Cocaine 22 61 57 90 
f--
Female Possession 
Heroin 28 44 41 42 
LSD 0 0 0 0 
Marijuana 210 223 248 234 
Cocaine 19 28 34 42 
= 
Sale 
Heroin 10 9 29 16 
LSD 0 0 0 0 
Marijuana I 8 15 28 
Cocaine 1 16 13 54 
All data courtesy Vermont Center for Justzce Research 
In addition to these troubling statistics, the heroin available for sale in Vermont is of 
higher purity (average 7 5-80%) than the national average of 37% (National Drug Intelligence 
Center, March 2003). Heroin is not generally available in Vermont on a wholesale level but 
rather is peddled by individuals, who purchase the drug from Dominican drug groups in larger 
. metro areas (Springfield, MA, New York, NY), transport it in small amounts back to their 
communities, where they then sell it to support their own habit (National Drug Intelligence 
Center). 
Evidence suggests that many of these users begin to participate in petty property crime in 
order to support their habits. As the habit becomes more entrenched, crime frequency and 
severity increases as well (Greater Baltimore Community, September, 1995). In addition to these 
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petty crimes, women in particular begin to participate in sexual trafficking to support their habits. 
This in turns leads to higher heterosexual incidence ofHIV/AIDS and viral hepatitis in the 
general population (University of California, San Francisco, 1996). 
As more and more individuals are convicted of crimes related to drug use/abuse, the rate 
of recidivism for these crimes increases. Due to the lack of treatment options for those entering 
the criminal justice system, any forced detoxification due to incarceration results in high rates of 
relapse (Boucher, Vermont Law Review, 2003). In testimony provided to the Vermont Senate's 
Health and Welfare Committee by Corrections Commissioner Steve Gold, many individuals are 
incarcerated as a result of a drug addiction (S. Gold, testimony, January 8, 2004) and Vermont 
currently has no protocol in place to administer methadone maintenance treatment (MMT) 
therapy. This dilemma has placed the Department in a bind as a result of court cases where 
denial ofMMT therapy was found to be unconstitutional as cruel and unusual punishment 
(Boucher). The corrections system is does not have the capacity nor does it want to get into the 
business of being heroin addiction treatment providers (Gold). 
In parallel to the criminal issues, Vermont enacted parity legislation in 1997 for substance 
abuse and mental health treatment. This legislation is considered a model of inclusiveness and 
has the broadest range of coverage of any other parity legislation within the United States 
(Rosenbach, Lake, Young, Conroy, Quinn, Ingels, Cox, Peterson, and Crozier, 2003). Five years 
after implementation of this legislation , Substance Abuse and Mental Health Services 
Administration (SAMHSA) conducted a study on the actual costs of parity in Vermont. The 
study found that while the feared increase in costs were not realized, actual payments for 
substance abuse treatment had reduced significantly from pre-parity levels. As the study's 
mandate was to examine direct costs only, no further investigation ofthis finding was conducted. 
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However, it is felt within the treatment and activist community that because these treatments are 
approved through managed care contractors (Magellan in Vermont), fewer people are seeking 
treatment on a chronic basis and may be relying more heavily on state welfare to provide 
treatment (personal conversation, Vermont Association for Mental Health Town Meeting Forum, 
April 19, 2004). This has an indirect cost to taxpayers and policyholders as the insurers in 
Vermont contribute to the state insurance pool. The stndy also showed an increase in inpatient 
care admissions for mental health treatment from pre-parity levels (Rosenbach, et.al). As 
substance abuse is often co-occurring with other mental health disorders (National Mental Health 
Association Fact Sheet, 2003) it is possible that more substance abuse treatment is occurring 
during these mental health treatment admissions but is not being coded as such. 
Vermont has an increasing prison population. The majority of this increase is attributable 
to substance abuse offenses, with alcohol being the primary offense, and heroin being the 
secondary (Zucacaro, Moore, Gray, Hogan, Hudson, 2004). Vermont has overcrowding in its 
prisons, exports some of its prison population at a staggering cost of $8m/year, and has 
commissioned a stndy to find the root cause of the overcrowding. The majority are non-violent 
offenders with substance abuse problems (Zucacaro, eta!). 
All of these background pieces help to create the very complex and challenging puzzle 
Vermont, as well as many other states, finds itself trying to solve. When confronting an 
expanding rate of drug arrests, an expansion of drug convictions, an expansion of incarcerations, 
especially among females, a contraction of services due to budgetary restraints and, a strain on 
the judicial system, the state is forced out of necessity to find some tolerable solution. The state 
found itself forced into examining drug court as an option to address this increasing problem 
(Vermont Judiciary, 2004). 
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Many communities within Vermont are opposed to the idea of treating drug offenders 
'lightly' through any diversion program (Governor's Heroin Action Committee, 2001). In 
Rutland, one of the communities with the highest proportion of addicts, the citizenry have 
protested vigorously against allowing any treatment facilities to be created within the town. Iu 
addition, at public forums sponsored by the Governor's Heroin Action Committee in the fall of 
2001, individuals within this community had the strongest opinions that drug offenders should be 
jailed and not treated (Governor's Heroin Action Committee, 2001). This antagonism may be a 
response generated by fear of becoming the next victim of a drug user through a mugging or 
burglary. 
Iu Rutland, the rate of crime associated with drugs, without factoring out for multiple 
offenses associated with one individual, has risen dramatically. Iu 2000, the rate/1,000 
population was 5.3%. By 2003, the rate had jumped to 10.31% (Vermont Crime Iuformation 
Center). And, while the gross population of Rutland decreased by 1.6% from 2000 to 2001, the 
number of drug crimes rose by 35%, with similar results for the period from 2001-2001 
(population decreased by .14%, drug crime rose by 34%). Rutland's population has grown by 
.014% from 2002 to 2003 and the drug crime rate has continued to rise, though not as 
dramatically, by 5.8%. 
The community of Chittenden County, which hosts the city of Burlington and has 24% of 
the total population of Vermont, was experiencing much the same rate of growth as Rutland. Iu 
2000, drug crimes from Chittenden accounted for 29% of all drug crimes in Vermont (Vermont 
Crime Iuformation Center). Iu 2001 it was 28.2%; 2002 it was 25.6% and in 2003 the rate was 
26.6% (Vermont Crime Iuformation Center). The primary difference between Chittenden and 
Rutland is the community's approach to the issue of drug use and abuse. 
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Chittenden was the first (and only still) community with an outpatient methadone clinic 
in Vermont. The clinic, housed in the Howard Center for Human Services in Burlington, 
Vermont, was opened in the summer of 2002 in association with Fletcher Allen Hospital, the 
teaching hospital ofthe University of Vermont Medical School. Prior to 2004, all methadone 
dispensation was mandated by legislation passed in 2000 to allow for methadone treatment 
options in Vermont, to be administered at a facility with a direct association with a hospital. 
Stand alone clinics were not allowed under the 2000 legislation. Chittenden also embraced the 
concept of a drug court, for adults and families, before the State approached the federal L 
govermnent for support. Chittenden is also studying the option of a juvenile drug court (Vermont 
Judiciary). 
These two communities are very different demographically. Rutland is the manufacturing 
hub of Vermont. The employment market focuses on unskilled or low skilled labor, commonly 
termed 'blue-collar' (U.S. Census). Educational levels are uniformly lower and unemployment is 
higher than in Chittenden county. Chittenden houses the state university, has the largest medical 
facility in Vermont with a Level One Trauma Center, a medical school, a large arts community 
and many social justice agencies. Chittenden has higher educational levels, more professional 
employment, and much greater racial diversity than any other community in Vermont (U.S. 
Census Bureau). 
It is within these two communities and the communities of Bennington County and 
Lamoile County that the state examined the potential of launching its pilot drug court programs. 
Bennington's program has just begun and Lamoile opted, after further consideration, to opt out 
of the pilot drug court program for the time being (Vermont Judiciary). Neither Bennington nor 
Lamoile will be included within the scope of this paper as a result. Although Chittenden had 
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already embarked upon this approach before the final report of the Dmg Court Pilot Project 
Committee within the state judiciary was completed, Chittenden is included in the pilot. As 
different as Rutland and Chittenden are in composition so are their respective approaches to dmg 
court development different. 
The Rutland Court has built upon the form developed by the judiciary committee. In 
conversations with the Dmg Court Coordinator in Rutland, Courtney Gandee, the program was 
created and given to her to implement (personal phone conversation, November 3, 2004) prior to 
her hire. Rutland has capacity for 35 participants with 18 currently participating. Termination has 
occurred with participants but Ms. Gandee did not have the data. Of the 18 current participants, 
60% are involved in heroin abuse and 22% abuse prescription opiates. The remaining 18% are 
involved with crack, cocaine, alcohol and/or marijuana. Rutland does not allow methadone as 
part of its treatment modality. Buprenorphine is used but its success is less well established than 
methadone and less effective with many opiate addicts (Centers for Disease Control, IDU/HIV 
Prevention, Febmary 2002). Rutland's program has not yet produced any graduates and the exact 
length of the program is evolving. Initially the program was designed for 6-12 months in active 
supervision and then 12 months post graduation observation. Also in the initial plan, upon 
graduation from the program, the criminal offense for which they were charged prior to entry to 
dmg court would be expunged from the offender's record. This approach is being re-examined as 
some participants are closing in on graduation. The adjustment will likely allow for expungement 
if the graduate is able to remain charge free for 12 months following graduation. 
Rutland's dmg court meets once a week, on Tuesdays, in the afternoon from 3 until4:30. 
Prior to court, the entire team, which includes the judge, the dmg court coordinator, prosecutors, 
the public defender and the case manager, meets to discuss the progress on each individual 
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participant. Any violations of the drug court participant contract are discussed as are any 
appropriate sanctions as well as rewards for compliance. Urine tests are taken weekly for 
compliance with abstention from illicit drug intake. It is accepted and expected that participants 
will lose ground during their tenure and have "slip ups". Thus, a positive urinalysis is not 
grounds for dismissal from the program. The Rutland program, which was initiated on January 4, 
2004, had its first week of zero positive drug tests the week of November 1, 2004. 
Rutland's wrap around services include vocational training, education opportunities 
(G.E.D, etc.), employment services, counseling, medical management of addiction, medical, 
dental and mental health care, and safe housing alternatives. This intensive effort to assist the 
individuals' in the drug court program will have lasting benefits by reducing crime, reducing the 
health burden untreated addicts have on society (reduction in ER use), and helping these 
individuals become productive members of society (Remple et al). Prevention and intervention 
have long proved to be more cost effective than incarceration (Boucher). These services 
continue 12 months post graduation. 
Rutland outlines its paper eligibility for drug court participation, i.e. the defendant meets 
certain threshold criteria, and further details how selection for drug court participation proceeds: 
To be admitted into Drug Court, you must be at least 18 years old and charged with 
certain drug possession, property crimes, or a violation of your probation for certain 
crimes. You may not have a history of violence. 
You must participate in a substance abuse screening and submit to a drug test. The 
screening takes place at the court before you are arraigned, or if necessary, at the 
correctional facility if you are detained on bail. You have the right to speak with your 
attorney before you decide to participate in screening. 
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The results of your screening will be used to determine your eligibility and create your 
treatment plan. The results cannot be used against you to bring new charges. The results 
of the screening will not be available to the public. You may need to go to detox before 
going any further with Drug Court. 
If your screening says that you are appropriate for Drug Court, you will have an 
assessment, which will take a few hours. Just as with the screening, the results of your 
assessment will not be used against you in court, but will be used to further determine if 
L 
you are right for Drug Court, and will only be shared with members of the Drug Court 
Team. (Rutland Drug Court Participant Handbook, 2004, page 6). 
Once paper eligibility has been determined and screening conducted, a conditional period 
of drug court participation commences. During this 'probationary" period, the participant can 
determine if he/she wishes to continue in the program and the drug court team can assess the 
appropriateness of the drug court program for the individual. After an individual completes the 
conditional period, he/she must sign a contract detailing his/her obligations and the drug court's 
obligations. No details of any sentencing agreements are included in the contract. 
Chittenden's approach is only slightly different and has three components as stated 
above; adult, juvenile and family drug courts (the juvenile court is not yet functioning but is in 
planning stages). Chittenden's program is marginally older and though they have collected data 
on graduates and have information on recidivism. To date, there have been a total of 6 graduates 
from the Adult Drug Court and 7 from the Family Drug Court. Of the six from Adult Court, one 
was on MMT and another was on Buprenorphine. Over the last 12 months (with graduations 
occurring at various times over that period) none ofthe graduates have recidivated. The 
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remaining four graduates from the Adult Court graduated drug free and have remained so 
(personal communication, December 2, 2004). Chittenden's process for both participation and 
termination from the drug court program are clearly defined in the handbook given to each 
participant. Although the sanctions outlined for failures of random drug tests indicates the 
participant may be terminated from the program after the fourth positive test, the actual practice 
has been far less stringent. The Chittenden Court has found that immediately applied sanctions 
for program participation violations, such as mandatory jail time, has been effective in allowing 
L 
participants to remain in the program (personal phone conversation, Mike Casarico, Adult Drug L 
Court Coordinator for Chittenden, December 2, 2004). Each individual is treated on a case by ~ 
case basis. This individualized approach, employed by Rutland County, Syracuse, New York and 
Ithaca, New York, allows for a more favorable outcome to participation. The objective is to 
produce as many graduates as possible and reduce recidivism and the ultimate societal costs 
associated with repeat offenders. 
The paper eligibility for Chittenden's Court is similar to Rutland's. Individuals who are 
charged with possession or property crimes in which drug use was the underlying motivator are 
paper eligible for the drug court program. The criteria supplied does not indicate whether there is 
a distinction between admissions for felony or misdemeanor charges. Individuals serving as an 
informant in drug investigations for consideration on pending charges are not eligible and 
individuals whom the state would seek to incarcerate regardless of their performance in the drug 
court program are not eligible (Protocol for Drug Court Treatment Program, Chittenden County, 
page 1 ). Ineligible charges include: Weapons offense, Homicides, Manslaughter, Sex Offenses, 
Escapes by sentenced Offenders, Aggravated Assault, Kidnapping, Unlawful Restraint, 
Domestic Crimes- incl. Stalking and Violations of Abuse Prevention Orders, Offenses involving 
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Alcohol/ISAP qualified (ATC Referral Sheet, Chittenden County). Some individuals who are 
charged with non-property crimes or other drug crimes may be eligible on a case by case basis. 
Currently, Chittenden supplies the same wrap around services as those employed by 
Rutland. Once the individual has graduated from the program, the case manager remains in 
contact but the coordinated facility of the available services ceases (personal phone conversation, 
M. Casarico, December 2, 2004). 
Chittenden is at a point where the judiciary feels some outcome measures should be 
provided to support the continued intense approach to interacting with these offenders, and the 
concomitant costs. Mr. Casarico is utilizing a recent study on the cost to benefit analysis of drug 
court versus the more conventional justice system approach. The study indicates that in 
Multnomah County, Oregon, the taxpayers save an average of$3596.92 per participant from 
entry into the drug court program until completion (S. Carey, M. Finnigan 2003). Based on the 
study's protocol, it would appear this type costs savings could be applied to the offending 
population in Vermont. 
According to Mr. Casarico, many participants who were struggling with the drug court 
program were eventually able to continue their participation in the program after entering the 
methadone maintenance treatment (MMT) program (personal email, November 16, 2004). It is 
this difference which is of interest to the author. 
The primary crux of this paper is to examine the relationship between the use of 
methadone in treatment regimens in drug courts and the prohibition of use of methadone; its 
effect on drug court participants who fail, who recidivate, and the long term effects on drug court 
graduates. 
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One of the primary sources utilized by the state of Vermont in its organization of drug 
courts was The New York State Adult Drug Court Evaluation, published in October 2003 
(Remple, Fox-Kralstein, Cissner, Cohen, Labriola, Farole, Bader and Magnani, 2003). This 
evaluation examines drug courts in over 11 areas of the state ofNew York, ranging from dense 
urban areas to rural courts. The data encompasses recidivism, treatment modalities, severity of 
addiction within the participant population, and long term effects with up to four years post 
graduation data in some jurisdictions. 
L 
As Vermont has such limited data on the subject, being nascent in drug court 
development, examination of this document may yield some insight into how to best organize the 
drug courts in Vermont. Rutland has begun using an MIS (management information system) 
modeled on the one used in Buffalo, New York, which is free. Although Buffalo has since 
stopped use of this MIS and now participates in the New York State MIS, this model may 
provide for some uniformity in data collection and thus more reliable results in data analysis if 
all jurisdictions within Vermont subscribe to the same system. This would require a 
standardization of classification for arrestees to ensure the data is consistent as recommended by 
the Vermont Judiciary Committee on the Drug Court Pilot Project. Without this standardization, 
evaluating results of drug court outcomes will be very difficult. 
The results from the meta-analyses of literature on drug courts in the United States and an 
in-depth review of data compiled within New York State, indicates some real and long lasting 
benefit of drug court problems. The need to address substance abuse among criminal offenders 
becomes more apparent with the revelation that overcrowding in prisons is a result of primarily 
non-violent offenders with substance abuse issues and the increased cost to the judiciary to 
process individuals charged with drug offenses or with property crimes related to a substance 
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addiction, is placing a fiscal and capacity strain on the state (Vermont Judiciary) and the 
recognition of most law enforcement agencies, governments and judiciaries that incarceration of 
drug crime offenders will not diminish the problem associated with illicit drug commerce 
(Vermont Judiciary, pg. 15). 
The New York Study compares data among jurisdictions and populations. The three 
courts examined in this paper for purposes of positing a possible plan for Vermont Drug Courts 
are Suffolk County, Syracuse, Brooklyn and Ithaca. Although Suffolk County is not 
representative of the Vermont population in size, it is similar in ethnicity and lessons from the 
program are quite interesting and worth examining. Brooklyn shares little or no demographic 
commonalities with Vermont, but the results oftheir program are also interesting and worth 
examining. Of the four programs from New York examined in this paper, only one, Brooklyn, 
does not allow any methadone as part of the treatment program (Remple, et. a!., page I 09). 
Syracuse tracks closely with Burlington (Chittenden County) on population, economic and 
educational demographics (U.S. Census). Ithaca tracks with Rutland on similar measures. 
Remple, et al's evaluation shows consistently that recidivism is significantly lower 
among drug court graduates regardless of the treatment modality employed (pg 109). It also 
found that younger people recidivated more often than older offenders and that non-drug 
property crime offenders recidivate more often than their drug crime offenders. In addition, 
property-crime offenders recidivate at a higher rate even as drug court graduates than their drug 
crime counterparts (pg 113). Drug court failures, i.e. those who enter the program but do not 
complete it, recidivate at a higher rate than non-drug court participants. Thus, the protection 
against re-offending is not found in the participation alone, but in actual graduation from the 
program (pg. I 09). This effect of graduation protection appears to lose its statistical significance 
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three years post program graduation. At that point, recidivism for both drug court graduates and 
non-drug court participants begins to equal out. 
The evidence from the evaluation would suggest a higher level of protection from re-
offending post-graduation after intense court supervision ceases. Drug court participants were 
more likely tore-offend during their active participation in the program than after graduating 
(pg. !13). Evidence also suggests a slightly higher level of protection against re-offending if 
methadone is allowed in the treatment period. (Remple et a!, page 1 09). 
In addition to the protective factor associated with drug graduation against recidivating, f--
there are other compelling benefits derived from drug court graduation. Across all nine courts 
analyzed by Remple, et a!, graduates were more likely to be employed, full or part-time at 
graduation, graduates from five of the programs were more likely to be enrolled in school, and 
graduates from some programs were able to retain custody of their children or negotiate greater 
visitation (page 1 00). 
Syracuse has the most inclusive eligibility requirements of any of the other 9 courts 
examined in the study (Remple, eta!, 2003). They will accept those with addictions to alcohol 
only, marijuana only, non-drug property crimes-misdemeanors and non-drug property crimes-
felony. One judge oversees the drug court which convenes two times per week. Prior to court, 
just as in Rutland, the judge meets with the entire team; the judge, court coordinator, case 
managers, public defender; to discuss each participant's progress. Sanctions are determined for 
non-compliance and rewards for compliance. 
Syracuse does allow for methadone within its treatment modality (Remple, et a!). 
Although the program works toward obtaining abstinence from methadone, it is not required that 
use of methadone be curbed by any degree for graduation from the program. 
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Misdemeanants may enter the program pre-plea (i.e. they do not have to admit guilt to 
any charges before entering the drug court program) and felony offenders may enter post-plea, 
though they may rescind and revise their plea if necessary after acceptance into the drug court 
program (Remple, et.al). Property crime defendants are recommended for the drug court program 
by their attorneys or the assistant district attorney (ADA) for the program. These defendants are 
individuals who are not currently charged with a drug related offense but who may be habitual 
offenders with substance abuse problems or their attorneys' may feel their property crime was 
motivated by an underlying substance addiction. 
Since Syracuse's drug court initiation in 1996, the eligibility standards have evolved. To 
standardize the evaluation conducted by Remple, et al, the sample control group (i.e. convicted f_-
offenders, non-drug court participants) was matched with the drug court participants' group r 
' 
based on charge (page 222). This method allows for the comparison of drug court failures', as 
well as graduates', recidivism with non-drug court participants. As Remple, et al found in the 
overall results, young age, failure and non-drug property crimes had higher rates of recidivism in 
Syracuse (page 229). 
Suffolk's drug court, initiated in 1996, eligibility requirements include felony and 
misdemeanor drug charges, as well as non-drug property crimes ifthere is an indication the 
defendant may have an underlying addiction. Defendants who are addicted to alcohol only are 
not eligible. As in most drug courts, prior non-violent convictions or probation violations are also 
eligible (Remple, et al., page 198). Those with severe mental or physical health issues, as well as 
those not motivated to participate in treatment, are ineligible. 
Sanctions and rewards as well as treatment programs are constructed on an individual 
basis. Thus, there is no standardized time requirement for completion (Remple, et al, page 197). 
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Each individual will proceed at their own pace. All Suffolk participants enter post-plea (i.e. have 
pled guilty to the charge) and have mandatory jail sentences imposed in the event of failure from 
the drug court (Remple et a!, page 199). If a participant is out on warrant (i.e. an unexcused 
absence from the drug court or progress meeting) or arrested on a new charge, the original jail 
sentence determined at arraignment may be amended and made substantially longer (Remple, et 
a!, page 202). 
The Brooklyn Drug Court is unique in that it admits the most severely addicted 
population and omits those who's use of drugs is considered causal or where the addiction is not L 
to a hard drug, i.e. heroin, crack or cocaine. Individuals only addicted to marijuana or alcohol are f 
not eligible (Remple, page 160). Refusal of treatment also makes the defendant ineligible. As 
with other courts, no prior violent convictions or evidence the possession of the illicit drug was 
intended for large scale distribution (amount confiscated is worth more than $4,000 in street 
value) (Remple, page !59) are admitted into the program. Methadone is not recognized as an 
acceptable treatment modality for Brooklyn's drug court participants. If a defendant is on MMT 
at the time of arrest, the defendant must be completely "clean" of methadone to graduate. 
Of particular interest is the fact that Brooklyn's drug court program has had the second 
highest number of participants in New York State's drug courts and has established a fairly high 
rate of graduates. On average, Brooklyn compares quite favorably to Syracuse and Suffolk in 
graduate numbers, even though it is working with a more difficult population. As with other 
courts, Brooklyn had higher rates of failures with those participants with prior property 
convictions (although non-drug property crime charges are not eligible for the Brooklyn 
program) and young age. 
Drug Courts in Vermont 19 
In comparing Suffolk and Brooklyn, the rates of recidivism among all drug court 
' graduates are similar. However, of particular interest is the finding that those individuals who 
indicate heroin as their primary drug of choice, have a higher rate of recidivism among the 
Brooklyn Drug Court graduates than among Suffolk's graduates. This effect may be explained 
by the use ofMMT in Suffolk and the prohibition ofMMT in Brooklyn. Other studies have 
indicated a higher rate of relapse among heroin addicts treated without methadone than those 
who are treated with MMT (Boucher). 
In Ithaca, the treatment for the substance addiction or abuse problem is not proscribed by 
the drug court team but rather by the participants' medical provider. No abstinence or reductions 
in methadone use are required by Ithaca on the basis that what is deemed medically necessary by 
a licensed physician for the treatment of the individual's malady is acceptable to the court. If a 
licensed physician states that methadone would be the best treatment, in combination with other 
wrap around services that is what is employed. This allows for more flexibility in treatment 
options for the drug court participants but it may also create less control through intimidation by 
the court to influence a defendant's behavior. 
Remple et al did not conduct a formal analysis oflthaca's program. However, the data 
included within their report indicates that Ithaca's approach may have a stronger effect on 
recidivism for drug charges, similar to those experienced by Suffolk County (page 325). As 
Remple, eta] rightly point out, a more thorough analyses needs to be conducted based on heroin 
as drug of choice and treatment modality, i.e. methadone maintenance vs. non-methadone 
maintenance. Heroin users are more likely to recidivate than other drug users. A study on the 
effects of the use or non-use of methadone maintenance on recidivism two to three years post 
graduation needs to be conducted in an effort to address the recidivism rate of this population. It 
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would also be interesting to see the effects on failme rates among drug court participants on 
methadone maintenance. In a conversation with Mike Remple, he indicated that although the 
New York Drug Court Study is suggestive that use of methadone maintenance for individuals' 
who's primary drug of choice is heroin may have an effect on both recidivism and drug court 
fail me, he would be cautious to generalize this suggestion to a larger population as it was not 
rigorously studied (phone conversation, November 22, 2004). Remple further clarified that the 
effect is not based on the charged offense but rather what participants indicate as their primary 
drug of choice upon intake to the drug court program. Thus, individuals charged with non-drug 
property crimes may have heroin as their primary drug of choice. The data does not make this 
distinction. As this measme does not include the control group, the results can not be 
extrapolated to the entire heroin using community. Further studies in this area would provide 
interesting data for use in drug court development. 
Conclusions: 
Remple et al's analysis ofNew York Drug Courts has some very interesting implications 
for how Vermont Drug Courts might operate. Of particular significance is the finding associated 
with recidivism and methadone treatment for heroin abusers. 
Hypothesis 2. More addictive primary drugs of choice predict a lower probability of drug 
court success. Specifically, heroin use predicts a lower probability of drug court success. 
The results confirm hypothesis 2, but with some qualifications. In two of three courts 
where heroin is a primary drug category (Brooklyn and Bronx), heroin users are less 
likely to graduate drug court. However, before generalizing, it is worth considering the 
impact of each court's methadone policies. In Brooklyn, there is a drug-free approach. 
This means that heroin users on methadone at the time of program entry must cut their 
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dosage in half before qualifying for completion of the first phase of treatment. Similarly, 
in Bronx, defendants on methadone at intake may become participants only if they agree 
to enter a methadone to abstinence program. Yet methadone maintenance is 
recommended for heroin dependence by the National Institute on Drug Abuse, due to the 
ability of methadone to alleviate heroin withdrawal symptoms. Accordingly, it is possible 
that in drug courts that do not require a methadone-to-abstinence approach, such as 
Suffolk and Syracuse where methadone may be used throughout drug court participation 
if deemed clinically advisable, a heroin addiction would have different implications. 
Indeed, the findings in Suffolk indicate that heroin users in that court are not more likely 
to fail drug court. In court-mandated treatment programs recently implemented across 
California, Longshore et a!. (2003) similarly report that a heroin addiction was associated 
with a lower probability of retention but also offer the caveat that the methadone 
maintenance modality was infrequently used; thus it is difficult to establish what the 
results would have been if methadone was used more often. (Remple et a!, page 127 ) 
As stated above, methadone treatment is the most accepted and well researched treatment 
for opiate dependence. Its use as a maintenance therapy for opiate addicts is endorsed by the 
federal government, by the National Institute on Drug Abuse, by SAMHSA, by the CDC, and so 
forth. Treatment has been shown to reduce the incidence of crime associated with maintaining a 
user's habit, which has the beneficial effect of making neighborhoods safer, cornrnunities more 
desirable, and businesses more prosperous. With the cost savings manifest in a drug court 
treatment program, Vermont would be well advised to follow the experience of other states and 
allow for MMT in their drug court protocol and treatment modalities. With the obvious 
comparisons to the use of other drugs for attaining better quality of life, such as insulin for 
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insulin dependent diabetics, or high blood pressure medication for hypertensives, methadone is 
another tool available to assist in the rising incidence of heroin use and addiction. No 
incarceration facility would consider denying heart medication or insulin to an individual within 
their control. The case can be made, strongly, thatMMT needs to be a vital component of any 
drug court program. The argument that drug addicts have caused this harm to themselves and 
thus they are not as deserving of humane and effective care is spurious. The same argument 
could be made of individuals who receive heart transplants due to cardiovascular diseases 
(CVD), often caused by being overweight, making poor food choices and being sedentary. 
Individuals who receive the intensive care necessary for CVD are no less 'guilty' of having self-
inflicted their ailment as a heroin addict. 
The cumulative cost of incarceration; facility cost, care and maintenance cost, personnel 
cost, victimization costs and societal costs (lack of productivity from incarcerated individuals), is 
far higher than the costs of preventive services. As in primary care, the cost of prevention is far 
less and efficacious than the cost of acute care. As long ago as Benjamin Franklin, before the 
advent of technology and antibiotics and high tech medical care, the adage of "an ounce of 
prevention is worth a pound of cure" applied to daily life. This aphorism is no less applicable to 
the situation faced now as it was to daily life in Franklin's time. The tremendous increase in 
prison construction has not lessened the amount of crime. The institutionalization of mandatory 
sentencing has not stemmed the number of individuals abusing illicit (and legal) substances. 
With alcohol being the most abused substance in the United States, the escalation of 
consequences associated with driving while intoxicated or under the influence has not stemmed 
the number of individuals arrested for these crimes in Vermont. The same is true for heroin. 
Addiction can not be effectively treated through a pnnitive approach. As there is little evidence 
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which supports incarceration, and the associated forced detoxification of heroin addicts which 
results, as an effective method to address the addiction, it would appear that diversion is the more 
cost effective and humane approach. Just as individuals who are arrested for driving while 
intoxicated or under the influence are not uniformly incarcerated, so too should individuals who 
use and abuse heroin not be incarcerated; at least not for the crime of possession alone. 
Obviously more serious offenses, such as violent crimes, should not escape conventional 
adjudication just because the underlying issue is a heroin addiction. 
As more states utilize diversion for drug offenses, the question becomes what is the most 
effective protocol for reducing recidivism among this population. As MMT has been evaluated 
and tested for well over three decades, its efficacy is well established and can not be denied. At 
least in the interim, until some other treatment method can be developed which does not replace 
one narcotic for another, MMT should be uniformly administered in the Vermont Drug Courts as 
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